Captain Hooked: The Addiction Project

From vaping bans to the fentanyl crisis, the U.S. is facing some of the most intense—and bizarre—challenges in the world of addiction. In this episode, addiction psychiatrist Dr. Wiplove (Wip) Lamba and addictions case manager Jean-Paul (JP) Michael break down the most pressing substance use trends shaping America today.With JP working on the front lines of addiction care at a major inner-city hospital in Canada and Wip bringing his expertise from clinical and academic work, they offer a unique outside perspective on the policies, trends, and controversies unfolding in the U.S. Whether it’s the explosion of fentanyl deaths, the shifting legal landscape of cannabis, or the unintended consequences of tele-health prescribing, they cover it all with honesty, insight, and just a bit of dark humour (humor)What’s in this episode? • How fentanyl became America’s deadliest drug • Big Pharma’s role in the opioid epidemic—have they really been held accountable? • MAT (Medication-Assisted Treatment)—the “gold standard” for opioid addiction, yet still out of reach for many • The U.S. criminal justice system: Why are people still being locked up for drug possession? • Veterans and addiction—why PTSD and substance use are so closely linked • The youth vaping crisis—how did it get this bad, and what’s being done? • The post-pandemic telehealth boom: a blessing or a disaster for addiction treatment? • Racial disparities in drug policy—who gets access to treatment, and who gets arrested? • Faith-based recovery—effective treatment or exclusionary approach? • Cannabis legalization—has it helped, or just created new problems?Why does this matter?America’s addiction crisis isn’t slowing down, and in many ways, it’s getting weirder. Harm reduction and treatment strategies continue to evolve, but so do the obstacles—whether it’s outdated policies, corporate greed, or new drug trends that emerge faster than regulators can react.As Canadians discussing a U.S. problem, JP and Wip provide a rare perspective: an outsider’s view of a system that seems chaotic, even compared to Canada’s often-criticized approach to addiction treatment. With years of frontline experience, they cut through the noise and get to the real issues—while keeping things engaging, informative, and unfiltered.🔗 Timestamps / Table of Contents:0:03 - Fentanyl Crisis and Overdose Epidemic7:26 - The Role of Big Pharma in the Opioid Epidemic9:39 - Medication-Assisted Treatment (MAT) Access12:02 - Criminalization vs. Treatment for Substance Use14:01 - Veterans and Addiction15:04 - Adolescent Vaping Crisis17:08 - Telehealth for Addiction Treatment Post-Pandemic21:06 - Racial Disparities in Addiction Treatment and Policy Enforcement22:17 - The Role of Faith-Based Programs in Addiction Recovery25:22 - State-Level Cannabis Legalization and Addiction Impacts📣 Join the Conversation:We’d love to hear your thoughts—leave a comment below! Have you or someone you know faced challenges in accessing quality addiction treatment? Share your story and let’s build awareness together.🎤 About the Hosts:Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove’s clinical and academic work.

In this detailed exploration, we delve into the alarming rise of Nitazene, a synthetic opioid significantly more potent than fentanyl. This video sheds light on the historical background, current impact, and the challenges posed by Nitazene in North America. We examine its interaction with other substances, its role in the increasing rates of opioid overdoses, and discuss the essential strategies needed for harm reduction and public health response. Join us as we uncover the complexities of this potent drug and its implications for addiction medicine and community safety.Table of Contents: 0:21 Introduction to Nitazene - The new, potent threat in the opioid crisis, its history, and why it’s known as “Frankenstein” among street names. 1:10 Historical Context and Resurgence - How Nitazene was developed, why it was never commercialized, and its recent detection in the drug market. 2:02 Current Impact and Public Health Response - Analyzing the surge in overdose deaths linked to Nitazene and the necessary public health strategies. 3:03 Medical Risks and Drug Interactions - The dangers of Nitazene when combined with other central nervous system depressants. 4:38 Challenges in Drug Detection and Response - The difficulties in detecting Nitazene in standard drug tests and the need for enhanced medical responses. 5:38 Strategies for Mitigation and Awareness - Discussing harm reduction, education, and community efforts to combat the spread of this dangerous opioid.Originally developed in the 1950s, Nitazene was never approved for medical use due to its extreme potency and associated risks. Decades later, these compounds have resurfaced in the illicit drug market, often mixed with other substances, increasing the danger they pose. This resurgence is especially concerning given the spike in overdose deaths in regions like Ontario and British Columbia, as well as in the U.S., particularly Philadelphia.This video explores the dual nature of opioids—beneficial under medical supervision but devastatingly dangerous when misused, especially in the form of black market products like Nitazene. It also highlights the critical interactions between Nitazene and central nervous system depressants, which can lead to severe, often fatal, respiratory depression.As the opioid crisis evolves, so does the complexity of the drug supply, introducing unpredictable risks with new synthetic opioids. This situation challenges first responders and addiction specialists who face the daunting task of combating these emerging threats. Our discussion extends to the effectiveness of naloxone, once considered a universal antidote, which now struggles against stronger opioids like Nitazene.The video concludes with a call to action for robust public health strategies, expanded research, and comprehensive community education to manage and mitigate the dangers posed by synthetic opioids. It underscores the need for a multifaceted response to a crisis that continues to evolve, testing the resilience and adaptability of our healthcare systems.References:1. Everything you need to know about nitazenes - The Pharmaceutical Journal (https://pharmaceutical-journal.com)2. Nitazenes: The New Fentanyl? | Poison Control (https://www.poison.org/articles/nitazenes-the-new-fentanyl-213)Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove’s clinical and academic work.

In this consequential episode, Jean-Paul Michael (Addiction Case Manager) and Dr. Wiplove Lamba (Addiction Psychiatrist) dissect the shocking findings from the Toronto Star’s investigation into Muskoka Recovery—a high-cost rehab facility that promised luxury care but delivered questionable credentials, dangerous oversights, and fatal consequences.With an addiction medicine lens, Jean-Paul and Dr. Lamba explore:Why fake credentials in addiction treatment can have life-or-death consequences: The gap between sky-high fees and the actual quality of care The lack of oversight in private recovery facilitiesMatthew Perry’s story and how it mirrors systemic issues in addiction care Concrete steps patients and families can take to verify healthcare providersThis episode isn’t just about pointing out failures—it’s about empowering viewers with the tools and knowledge needed to navigate the complex world of addiction treatment safely🔗 Timestamps / Table of Contents:0:00 - Introduction4:30 - The Problem with Misrepresentation in Recovery Spaces12:15 - High Costs vs. Quality of Care18:45 - Matthew Perry's Story and Lessons Learned25:00 - The Role of Regulation in Treatment Facilities32:15 - Detox Protocols and Medical Oversight38:40 - Personal Story: Jean-Paul’s Exp with a Recovery Coach45:10 - What Makes a Recovery Program Effective?50:30 - The Ethical Responsibility of Treatment Providers55:00 - Final Reflections and Takeaways🛡️ How to Verify Healthcare Providers in Ontario🛡️ If you're seeking addiction treatment, make sure the professionals you or your loved ones interact with are licensed and qualified. Here's how:Social Workers & Social Service Workers:Visit: OCSWSSW.orgUse the "Online Register Search" tool to verify a professional's registration number, first name, or last name.Physicians:Visit: CPSO.on.caUse the "Physician Register" tool to search by CPSO number or name.Nurses:Visit: CNO.orgUse the "Find a Nurse" tool to confirm a nurse’s status.ConnexOntario – For Addiction and Mental Health Support:Website: connexontario.caEmail: connexontario.ca/email-usPhone: 1-866-531-2600 (24/7 Helpline)ConnexOntario provides free, confidential support and connects individuals to verified addiction and mental health services across Ontario.🔑 Key Takeaways:Fake credentials kill: Unverified professionals can pose life-threatening risks.Price ≠ Quality: Expensive facilities aren't always the safest or most effective.Transparency saves lives: Families must demand clear, honest information about treatment plans and credentials.Medical oversight is critical: Detox requires trained professionals.Accountability matters: Facilities must be held responsible for failures in care.🎤 About the Hosts:Jean-Paul Michael: Addiction Case Manager with years of frontline experience in addiction care. Dr. Wiplove Lamba: Addiction Psychiatrist and advocate for evidence-based treatment practices. Together, they offer a raw, insightful perspective on the realities of addiction medicine, with professional analysis and deeply personal reflections.

In this episode, co-hosts Dr. Wiplove (Wip) Lamba and Jean-Paul (JP) Michael dive into the crucial question, “Is Harm Reduction Dead?” as they examine the life-saving impact and broader, often-overlooked benefits of safe consumption sites (SCS). Far beyond reducing overdose deaths, SCS provide primary care and other vital services to individuals who may otherwise be excluded from the healthcare system. These services not only save lives but also reduce taxpayer costs, hospital visits, and emergency wait times by offering proactive, accessible care to those in need. Through his personal narrative, JP shares how harm reduction was the only viable pathway for someone like him, who was completely disenfranchised from the existing healthcare system. JP and Wip shed light on the critical support that safe consumption sites provide, creating an environment where individuals can access care, foster trust, and connect with services they might otherwise avoid due to stigma or past negative experiences. This episode challenges the misconception that harm reduction is incompatible with recovery and argues instead for a broader understanding. Harm reduction doesn’t only serve as a pathway to safer use; it supports diverse approaches, including recovery, tailored to meet people where they are. JP and Wip explore the ethical, logistical, and public health benefits of harm reduction, encouraging listeners to see these sites as essential resources that empower individuals and strengthen communities. • 00:00 – Clips from the Episode • 00:50 – Opening Remarks: Is Harm Reduction Dead? • 02:12 – Addressing the Harm Reduction Misconceptions • 05:37 – How Safe Consumption Sites Save Lives • 09:08 – Primary Care in SCS: Reducing Hospital Strain • 12:46 – JP’s Story: Harm Reduction as a Pathway for the Disenfranchised • 17:20 – Stigma’s Role in Limiting Access to Care • 21:30 – Harm Reduction as a Spectrum: Safe Use and Recovery • 25:48 – Public Health Impact: Fewer Overdoses, Less ER Strain • 28:40 – Medical Ethics: Wip’s Perspective on Supervised Use • 32:14 – Success Stories: How SCS Make a Difference • 36:05 – Closing Thoughts: The Future of Harm Reduction Why This Matters: Safe consumption sites are pillars of harm reduction, providing more than just a safe space—they’re lifelines offering medical care, reducing strain on hospitals, and cutting taxpayer costs by preventing crises before they reach emergency rooms. JP and Wip draw from their extensive experience to show how SCS not only save lives but also create healthier, more supportive communities. References Consumption and Treatment Services (CTS): Windsor-Essex Community Opioid and Substance Strategy (WECOSS). https://wecoss.ca/sites/default/files/WECOOSS Presentation Jan 2021.pdf Safer Supply Programs: Understanding Harm Reduction and Consumption Treatment Services, Middlesex-London Health Unit. https://www.healthunit.com/harm-reduction Overdose Prevention Sites (OPS): Moss Park OPS, Toronto. Toronto Star (2017). https://www.thestar.com/news/gta/2017/09/27/unsanctioned-pop-up-supervised-injection-site-in-moss-park-dismantled-as-funding-begins-for-legal-site.html Syringe-Dispensing Programs (Vending Machines): Harm Reduction Journal, Syringe-Dispensing Machine Needle Exchange Program. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00541-z Safer Supply Myths (Kadian): Middlesex-London Health Unit. https://www.healthunit.com/harm-reduction Featuring Dr. Wip, an addiction psychiatrist, and Jean-Paul (JP) Michael, an addiction case manager and former addict. They explore various facets of substance use, addiction medicine, psychotherapy, harm reduction, treatment, and recovery. JP works daily in a leading inner-city hospital in Canada’s largest city, while Dr. Wip’s work encompasses both clinical practice and academic contributions.

Chapters 0:00 introduction 1:13 Seek Support if Needed 1:51 Monitor Your Emotional State 2:22 Practice Saying No 2:56 Plan Safe Transportation 3:38 Choose Lower Alcohol Options 4:10 Avoid Drinking Games and Shots 5:01 Pace Your Drinks 5:33 Eat Before and While Drinking 6:28 Stay Hydrated 7:03 Know Your Limits 7:48 Conclusion In today’s YouTube video, we embark on an enlightening journey to celebrate the art of moderation, exploring the wisdom of setting limits and the joy of conscious celebration without the aftermath of regrettable decisions, such as waking up with a mystery tattoo. We acknowledge that while no amount of alcohol is deemed ‘healthy’ for the body, not all drinking behaviors carry the same level of risk. This presentation delves into the sparkling realm of harm reduction drinking tips, advocating for choices that prioritize well-being and safety over excess. Our guide is a thoughtfully curated Top 10 Countdown of Harm Reduction Drinking Tips, designed to inspire viewers to toast to their health with confidence and knowledge. These tips range from seeking support if controlling alcohol intake becomes challenging, to monitoring emotional states, as alcohol can intensify emotions and potentially lead to dependency. We emphasize the power of saying no to peer pressure and the importance of planning safe transportation to avoid impaired driving. The countdown continues with practical advice on choosing drinks with lower alcohol content, avoiding high-risk behaviors like drinking games and shots, and pacing drinks to allow the body time to metabolize alcohol safely. We also stress the importance of eating before and while drinking to slow alcohol absorption, staying hydrated to counteract alcohol’s dehydrating effects, and, most importantly, knowing your personal limits to prevent overindulgence. Concluding, our video underscores that less harmful drinking is about making informed choices, understanding risks, and implementing strategies to reduce negative outcomes. By embracing these ten harm reduction tips, viewers are encouraged to enjoy social occasions with mindfulness and control. This approach to drinking is not about achieving perfection but about taking practical steps towards a safer and more enjoyable experience. Join us in promoting healthier choices and celebrating the art of moderation for a happier, safer social life. Canada’s safer drinking guidelines https://www.ccsa.ca/sites/default/fil... Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove’s clinical and academic work.

Chasing the dragon, trying to recreate the first high. After the episode on chandler and his ketamine related death, Wip asked JP questions about ketamine and tolerance based on his past history of personal use. While there are differences in the use if ketamine for depression vs addiction, for some people, self titration to effect is not realistic. Medicine also has history of iatrogenic harms caused by prescribed drugs. We hope this conversation is interesting for you and we look forward to hearing your feedback and thoughts. In this engaging addiction medicine podcast episode, our hosts delve deep into the world of addiction, tolerance, and its various facets. They discuss the concept of "chasing the dragon," where individuals continuously pursue the euphoric sensation of their initial high, drawing parallels to addiction dynamics. The hosts candidly reflect on their own experiences and perspectives, highlighting the importance of curiosity and empathy in understanding addiction. Table of Contents 00:00 "Chasing the Dragon" What is "chasing the dragon," and how does it relate to addiction? Exploring the persistent pursuit of the initial high. The impact of chasing the dragon on individuals and their struggles. 01:40 "The Relevance of Tolerance" How does tolerance play a crucial role in addiction? Differentiating between tolerance and its effects on various substances. Why tolerance matters and its implications for treatment and recovery. 04:40 "Routes of Administration and Absorption" Examining the significance of different administration methods. IV, intranasal, and oral absorption: What are the differences? How absorption rates affect tolerance and addiction potential. 05:38 "Understanding Vulnerability" Why do some individuals have a unique response to substances? Unpacking the experiences of those who feel a positive impact from opiates or ketamine. The importance of recognizing individual differences in addiction risk. This thought-provoking podcast episode offers valuable insights into addiction, tolerance, and the complexities surrounding substance use disorders. Join the hosts as they navigate these topics with empathy, curiosity, and a genuine desire to promote understanding and awareness in the field of addiction medicine. Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove’s clinical and academic work. The content should not be taken as direct medical advice or clinical instruction.

(This video was solely the work of Jean-Paul Michael, I apologize in advance if this video offends anyone. The concept of someone "faking" an overdose was viscerally disturbing to me as a former substance user. I needed to address it.)  In this impactful episode of our addiction medicine podcast, we diverge from our regular content to present a sobering and educational perspective. We scrutinize body cam footage documenting the final moments of Jean DesCamps, a 26-year-old man, at an Oregon hospital. This episode is a reminder of the complex nature of situations involving substance abuse. We aim to shed light on issues such as potential overdose, malingering, and the critical need for behavioral awareness in a non-judgmental manner, fostering a learning opportunity and addressing stigma in addiction. Jean DesCamps was discovered in a state of distress on Portland’s TriMet MAX train and was taken to Providence Milwaukie Hospital. Despite exhibiting symptoms of opioid intoxication, the response was limited, focusing more on perceived behavioral problems than on a comprehensive medical evaluation. This approach raises important questions about the assessment and treatment of patients with substance use histories. The body cam footage reveals DesCamps in an obtunded state, clearly struggling to communicate, groaning, and drooling. The decision by a medical to suggest removing him to a bus stop, under the assumption that his condition was feigned, becomes a focal point for discussion. This scenario illustrates the challenges in making accurate assessments and the potential for critical misinterpretation in treating patients with addiction. Law enforcement’s role is also highlighted in the episode. Called to assist with DesCamps’ removal from the hospital, the officers’ reluctance and their recorded conversations demonstrate the ethical challenges they face. Their eventual decision to take him to Unity Behavioral Medical Center, and what followed, underscores the serious nature of DesCamps’ condition. Our discussion is intended to stimulate thought and conversation, not to assign blame. We explore the intersections of medical care, addiction, and law enforcement, emphasizing the need for empathy and appropriate training in managing addiction cases. The graphic content, though presented carefully, is essential to convey the educational aspect of this tragic event. Our goal is to honor Jean DesCamps’ memory by encouraging discussions about improving practices in addiction medicine and emergency care. Viewer discretion is advised for the graphic content of this episode. Featuring addiction case manager and former addict Jean-Paul (JP) Michael, the channel focuses on all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. JP shares his motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city.

A few months back we went through Matthew Perry autobiography. https://youtu.be/xBFxfMvihLY?si=qwaDkhgwvQTyv5PX It was quite a shock to hear he had passed away. In this episode, we discuss the nuances around addiction, medical treatment and the self-medication. We begin by examining the public perception of sobriety, using Matthew Perry's tragic story to illustrate the struggles of addiction under the public eye and the pressure accompanying it. The conversation then shifts to ketamine, a drug gaining attention for its potential in treating depression, while also posing risks for misuse and abuse. Table of Contents 00:00:00 - 4 clips from episode 00:00:50 - Start - Why are we taking about ketamine? 00:01:25 - Pro/cons ketamine as medicine 00:06:32 - Celebrities and addiction 00:08:26 - JP personal experience with ketamine - tolerance, heightened enjoyment 00:13:37 - Why do some people use ketamine? 00:16:41 - Can we self medicate//shame and recovery 00:22:35 - Can celebrities get good medical care? 00:25:21 - Unscheduled pause (1 of 6) - due to Premiere Pro upgrade 00:26:07 - What to do in a world with unlimited access to drugs of abuse. 00:28:10 - Public health inverted U curve on prohibition vs government regulation of drugs. A historical perspective on the use and abuse of various substances in medicine sets the context for current addiction treatment challenges. The experts caution against overlooking ketamine's abuse potential, emphasizing careful consideration in its therapeutic use. They also discuss the burgeoning interest in psychedelics for mental health treatment, stressing the need for caution and awareness. A significant part of the discussion centers on the dangers of self-titration and microdosing, especially with drugs like ketamine. Personal experiences are shared, providing insights into the use of various substances and their impact. The unpredictability of drug-induced thought patterns and the ethical dilemmas in using drugs for depression treatment are explored. Socioeconomic factors in drug accessibility and effects, along with celebrity cases like Michael Jackson and Matthew Perry, are analyzed to understand addiction treatment complexities in different social contexts. The emotional challenges of relapse, stigma, and the importance of supportive recovery environments are discussed. The podcast also delves into tolerance development in drug use, particularly with ketamine, and the cultural and recreational aspects of its use. The complex relationship between drugs and emotions is highlighted, underscoring the importance of considering these effects in treatment. This episode offers a thought-provoking exploration of addiction treatment, the balance between medication and self-medication, and the ethical considerations in mental health treatment with substances like ketamine. It's a deep dive into the delicate intricacies of addiction and recovery. Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove’s clinical and academic work.

The podcast episode primarily revolves around the complex issues of addiction medicine, with a significant focus on the concept of safer supply in drug policy. The hosts begin by discussing their recent visit to Vancouver Island for an addiction conference, leading into a conversation about the Drug User Liberation Front (DULF), an advocacy group that has been in the news. A major point of discussion is the arrest of DULF members, who were involved in efforts to provide a controlled and safer supply of drugs. This action by the police raises questions about the challenges and legalities surrounding efforts to mitigate the risks of the toxic illicit drug supply. The hosts discuss the implications of these arrests and the broader impact on harm reduction initiatives. The conversation then delves into the specifics of DULF's approach to safer supply, highlighting how the group's activities aimed to reduce harm by controlling the quality of the drug supply. This leads to a broader discussion on drug policy analysis, with references to experts like Karen Ward and the importance of studies that suggest reduced drug use and overdose risks with safer supply methods. Funding for such initiatives is another key topic. The hosts scrutinize the government's stance on funding harm reduction and safer supply programs, noting the controversy and political challenges in sustaining these programs. They emphasize the need for drug checking services and harm reduction equipment in the context of safer supply. The ethical dilemmas faced by healthcare professionals in prescribing drugs for harm reduction are discussed, particularly concerning substances like fentanyl and hydromorphone. The hosts question the traditional roles and responsibilities of healthcare providers in the context of a safer supply model. Attention is given to the impact of these policies on youth and the broader societal implications. The hosts express concerns about young people's exposure to substances under safer supply initiatives and the long-term effects on their potential and health. In the concluding segments, the hosts reflect on the need for a balanced approach that incorporates diverse perspectives in drug policy. They call for sensible and practical solutions that navigate the complexities of providing a safer supply while considering the broader societal and political implications. Overall, the podcast offers a comprehensive exploration of the safer supply concept in addiction medicine, emphasizing the need for nuanced and informed approaches in drug policy and harm reduction efforts. Table of Contents 00:00:04 - Introduction: Focus on Safer Supply in Addiction Medicine 00:00:44 - Arrests of DULF Members and Impact on Safer Supply 00:01:17 - Discussing DULF's Safer Supply Approach 00:02:09 - Controversies in Funding Safer Supply Initiatives 00:07:27 - Challenges in Drug Testing: Fentanyl and Safer Supply 00:09:33 - Ethical Considerations in Prescribing for Safer Supply 00:21:17 - The Role of Prescribing Practices in Safer Supply 00:25:52 - Youth Impact in the Context of Safer Supply Policies 00:29:07 - Societal and Political Dimensions of Safer Supply 00:37:15 - Conclusion: Future of Safer Supply in Addiction Medicine Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove’s clinical and academic work. #Lived experience #addiction #recovery #addiction medicine #DULF #cocaine, #Heroin, #safe supply #decriminalization

CSAM (Canadian Society of Addiction Medicine) has extended an invitation to our very own Dr. Wip to present their 2023 Lifetime Achievement Award to his mentor, Dr. Shelby. Dr. Wip elucidates the profound influence and enduring impact that Dr. Shelby has had on his journey. Dr. Peter Selby is a Clinician Scientist and Senior Medical Consultant at CAMH. He is the Interim Vice-Chair of Research for the Department of Family and Community Medicine and holds the Dr. Barnett & Beverley Giblon Professorship in Family Medicine Research at the University of Toronto. He is a Clinician Scientist and Director of the Mental Health and Addictions Division in the Department of Family and Community Medicine. He is also a Professor in the Department of Psychiatry and in the Dalla Lana School of Public Health at the University of Toronto. He is also a full member of the School of Graduate Studies through the Dalla Lana School of Public Health and the Institute of Medical Sciences at the University of Toronto. Areas of Research Dr. Selby's research focus is innovative methods to understand and treat addictive behaviours and their comorbidities. He also uses technology to combine clinical medicine and public health methods to scale up and test health interventions. His cohort of 280,000+ treated smokers in Ontario is an example. His most recent program of research utilizes a Learning Health Systems approach to investigate how technology enabled collaborative care can enhance the delivery of evidence-based interventions to the patient while providing a more satisfying experience of care for both patient and provider. Dr. Selby has received grant funding totaling over 100 million dollars from CIHR, NIH, and Ministry of Health, and has published 38 research reports prepared for the government. Dr. Selby mentors residents and faculty from a variety of disciplines. He is a sought after speaker for various topics including addictive disorders, motivational interviewing, and health behavior change at individual and system levels. Publications Dr. Selby has published over 150 peer-reviewed articles, 37 books or book chapters, and 125 international presentations. https://csamconference.org/ Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove’s clinical and academic work. The content should not be taken as direct medical advice or clinical instruction.